Anúncio
Anúncio

CLRB

CLRB logo

Cellectar Biosciences INC NEW

3.30
USD
Patrocinado
-0.02
-0.66%
08 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

3.37

+0.07
+2.03%

Relatórios de Lucros CLRB

Rácio de surpresa positiva

CLRB separação 19 de 38 últimas estimativas.

50%

Próximo Relatório

Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.06
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+46.10%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+14.44%

Cellectar Biosciences INC NEW earnings per share and revenue

On 13 de nov. de 2025, CLRB reported earnings of -1.41 USD per share (EPS) for Q3 25, beating the estimate of -2.57 USD, resulting in a 45.31% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -18.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -2.06 USD, with revenue projected to reach -- USD, implying an aumentar of 46.10% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
FAQ
For Q3 2025, Cellectar Biosciences INC NEW reported EPS of -$1.41, beating estimates by 45.31%, and revenue of $0.00, 0% as expectations.
The stock price moved down -18%, changed from $3.50 before the earnings release to $2.87 the day after.
The next earning report is scheduled for 11 de mar. de 2026.
Based on 6 analistas, Cellectar Biosciences INC NEW is expected to report EPS of -$2.06 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio